Emergency contraception from the pharmacy 20 years on: a mystery shopper study
- PMID: 32554399
- PMCID: PMC7815628
- DOI: 10.1136/bmjsrh-2020-200648
Emergency contraception from the pharmacy 20 years on: a mystery shopper study
Abstract
Background: Emergency contraception (EC) was approved in the UK as a pharmacy medicine for purchase without prescription in 2001. Twenty years later we conducted a study to characterise routine practice pharmacy provision of EC.
Study design: Mystery shopper study of 30 pharmacies in Edinburgh, Dundee and London participating in a clinical trial of contraception after EC.
Methods: Mystery shoppers, aged ≥16 years, followed a standard scenario requesting EC. After the pharmacy visit, they completed a proforma recording the duration of the consultation, where it took place, and whether advice was given to them about the importance of ongoing contraception after EC.
Results: Fifty-five mystery shopper visits were conducted. The median reported duration of the consultation with the pharmacist was 6 (range 1-18) min. Consultations took place in a private room in 34 cases (62%) and at the shop counter in the remainder. In 27 cases (49%) women received advice about ongoing contraception. Eleven women (20%) left the pharmacy without EC due to lack of supplies or of a trained pharmacist. Most women were generally positive about the consultation.
Conclusions: While availability of EC from UK pharmacies has undoubtedly improved access, the necessity to have a consultation, however helpful, with a pharmacist introduces delays and around one in five of our mystery shoppers left without getting EC. Consultations in private are not always possible and little advice is given about ongoing contraception. It is time to make EC available without a pharmacy consultation.
Keywords: contraceptive agents, female; contraceptives, postcoital; pharmaceutical services; surveys and questionnaires.
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.
Conflict of interest statement
Competing interests: AG is a member of HRA Pharma scientific advisory board. PB is a Clinical Director of the not-for profit community interest company SH:24 that provides online sexual health services in partnership with the NHS. AR is in receipt of research grants, educational grants and consultancy with Gilead, research grants from Roche and BMS, and educational grants from Abbvie. JN is Deputy Chair of the NIHR/HTA General Board Committee. NIHR/HTA funded this research.
Comment in
-
Emergency contraception from community pharmacies: looking back and looking forward.BMJ Sex Reprod Health. 2021 Jan;47(1):4-5. doi: 10.1136/bmjsrh-2020-200767. Epub 2020 Sep 8. BMJ Sex Reprod Health. 2021. PMID: 32900794 No abstract available.
References
-
- Office for National Statistics Contraception and sexual health. London: Office for National Statistics (ONS), 2003. https://data.gov.uk/dataset/7d82e0e2-4533-4c0d-bfc1-7ecd1a3c674d/contrac...
-
- Office for National Statistics Contraception and sexual health. London: Office for National Statistics (ONS), 2009. https://data.gov.uk/dataset/7d82e0e2-4533-4c0d-bfc1-7ecd1a3c674d/contrac...
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources